All my statements are my opinion after performing extensive due diligence. No statement of mine should be taken as investment advice or as an attempt to solicit a buy or sell of a security. Invest wisely.
Recent PRTA News
- Prothena to Participate in Upcoming Healthcare Conferences • Business Wire • 08/29/2024 08:05:00 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 08/08/2024 09:13:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2024 08:14:46 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2024 08:09:02 PM
- Prothena Reports Second Quarter 2024 Financial Results and Business Highlights • Business Wire • 08/08/2024 08:05:00 PM
- Prothena to Report Second Quarter 2024 Financial Results on August 8 • Business Wire • 08/01/2024 08:05:00 PM
- Prothena Announces Bristol Myers Squibb Opt-in for Exclusive Global License for PRX019, the Second Program from Global Neuroscience Research and Development Collaboration • Business Wire • 05/28/2024 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/17/2024 08:42:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/17/2024 08:37:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/17/2024 08:29:44 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/17/2024 08:08:55 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/08/2024 08:19:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/08/2024 08:09:01 PM
- Prothena Reports First Quarter 2024 Financial Results and Business Highlights • Business Wire • 05/08/2024 08:05:00 PM
- Prothena to Report First Quarter 2024 Financial Results on May 8 • Business Wire • 05/01/2024 08:05:00 PM
- Prothena Announces Review on Birtamimab Mechanism of Action and Pharmacological Characteristics Published in Leukemia & Lymphoma • Business Wire • 04/15/2024 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 02:03:16 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 02:01:40 AM
- Prothena to Participate in Upcoming Healthcare Conferences • Business Wire • 03/05/2024 09:05:00 PM
- Prothena Appoints David Ford to Newly Created Chief People Officer Position • Business Wire • 03/04/2024 09:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/01/2024 02:11:54 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/01/2024 02:09:37 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/01/2024 02:08:29 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/01/2024 02:06:06 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/01/2024 02:03:58 AM
Lingerie Fighting Championships Signs Broadcast Deal With Maybacks Global Entertainment • BOTY • Sep 26, 2024 9:00 AM
Maybacks Global Entertainment and Lingerie Fighting Championships Enter Into Broadcast And Revenue Sharing Agreement • AHRO • Sep 26, 2024 8:30 AM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM